| |
|
he recent application of mesoporous silicas extended to controlled drug delivery has raised much interest due to their non-toxic nature, high surface area, large pore volume, tunable pore size and chemically modifiable surfaces, allowing them to be potential hosts for various |
drugs, such as Ibuprofen, Amoxicillin, Gentamicin, Captopril, or even large protein drugs. Hydrogels – which belong to one category of widely employed polymer-drug matrices – are cross-linked macromolecular networks swollen in water or biological fluids. Due to their good biocompatibility and sensitivity in the physiological or biological environment, hydrogels have been found in numerous applications in the fields of biology and medicine including ophthalmological devices, biosensors, scaffold, and controlled drug delivery systems.
For the first time, a team of NUS researchers has successfully combined these two types of interesting materials together to fabricate a pH-sensitive drug delivery system. Figure 1 shows the TEM images of mesoporous silica before and after being encapsulated with hydrogel. It can be seen that after being encapsulated with hydrogel, the parallel channels of mesoporous materials are covered by hydrogel (Figure 1(c)), and from a cross-sectional view, a thick layer of PAA (around 10 nm) could be observed on the outer surface of SBA-15 (Figure 1(d)).
|
|
|
In this system, the protein drug can be held in the mesoporous channels at a lower pH value of 1.2 while it is released at a higher pH value of 7.4 (Figure 2). Comparing with previous work which used multilayers of polyelectrolyte pairs whereby drugs or proteins were released more at lower pH value rather than at higher pH value, the results obtained by the NUS team show a much better therapeutical significance, because on most occasions, drugs – especially protein drugs – used to be protected from the stomach (at pH 1-3) but released to the intestine (at pH 6-8). It is therefore believed that this pH-responsive drug delivery system should have a potential application for oral delivery of drugs. Furthermore, the conformation of released protein drugs has not been seriously affected, suggesting that the function and efficacy of the protein can be well maintained after encapsulation and release from this drug delivery system.
|
|